UK markets closed

Medtronic plc (MDT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
79.74+0.49 (+0.62%)
At close: 04:00PM EDT
79.74 0.00 (0.00%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 105.88B
Enterprise value 122.74B
Trailing P/E 25.31
Forward P/E 14.60
PEG ratio (5-yr expected) 1.51
Price/sales (ttm)3.29
Price/book (mrq)2.04
Enterprise value/revenue 3.80
Enterprise value/EBITDA 13.78

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3-12.06%
S&P500 52-week change 322.36%
52-week high 392.02
52-week low 368.84
50-day moving average 383.48
200-day moving average 381.55

Share statistics

Avg vol (3-month) 36.33M
Avg vol (10-day) 35.95M
Shares outstanding 51.33B
Implied shares outstanding 61.33B
Float 81.33B
% held by insiders 10.11%
% held by institutions 185.25%
Shares short (15 Apr 2024) 412.39M
Short ratio (15 Apr 2024) 41.9
Short % of float (15 Apr 2024) 40.93%
Short % of shares outstanding (15 Apr 2024) 40.93%
Shares short (prior month 15 Mar 2024) 411.53M

Dividends & splits

Forward annual dividend rate 42.76
Forward annual dividend yield 43.46%
Trailing annual dividend rate 32.75
Trailing annual dividend yield 33.47%
5-year average dividend yield 42.50
Payout ratio 487.30%
Dividend date 312 Apr 2024
Ex-dividend date 421 Mar 2024
Last split factor 22:1
Last split date 327 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 28 Apr 2023
Most-recent quarter (mrq)26 Jan 2024

Profitability

Profit margin 13.00%
Operating margin (ttm)19.17%

Management effectiveness

Return on assets (ttm)4.23%
Return on equity (ttm)8.17%

Income statement

Revenue (ttm)32.32B
Revenue per share (ttm)24.30
Quarterly revenue growth (yoy)4.70%
Gross profit (ttm)N/A
EBITDA 8.68B
Net income avi to common (ttm)4.2B
Diluted EPS (ttm)3.15
Quarterly earnings growth (yoy)8.20%

Balance sheet

Total cash (mrq)8.32B
Total cash per share (mrq)6.27
Total debt (mrq)25.18B
Total debt/equity (mrq)48.43%
Current ratio (mrq)2.30
Book value per share (mrq)38.95

Cash flow statement

Operating cash flow (ttm)6.47B
Levered free cash flow (ttm)5.51B